Skip to content
value.today

Axiomed Spine Corp.

Total raised
$25 M
5 rounds on record
Latest round
$1 M
Apr 2014
First round on record
Nov 2009
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Axiomed Spine Corp.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2014$1 MNo. 5Under $2 million

Axiomed Spine Corp.: Raise no. 5, Apr 2014

Investors in this round

14 investors had bought by the notice of Apr 29, 2014: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $1 M still to sell
Smallest investment taken
$1,404
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gerald G. Baty · Executive Officer
  • James M. Kuras · Executive Officer, Director
  • Patrick A. McBrayer · Executive Officer, Director
  • Ashley G. Friedman · Director
  • Kathleen A. Tune · Director
  • Keith G. Kerman · Director
  • Larry A. Papasan · Director
  • Peter G. Kleinhenz · Director
  • Peter G. McNerney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Patrick A. McBrayer, President and Chief Executive Officer. Newest notice filed Apr 29, 2014. Read the notice at the SEC.

debt, optionsSEC
Jan 2013$4 MNo. 4$2 to $10 million

Axiomed Spine Corp.: Raise no. 4, Jan 2013

Investors in this round

15 investors had bought by the notice of Jan 18, 2013: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
$9,950
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gerald G. Baty · Executive Officer
  • James M. Kuras · Executive Officer, Director
  • Patrick A. McBrayer · Executive Officer, Director
  • Ashley G. Friedman · Director
  • Keith G. Kerman · Director
  • Larry A. Papasan · Director
  • Peter G. Kleinhenz · Director
  • Peter G. McNerney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The proceeds of the offering are to be used for working capital purposes.”

Signed by Patrick A. McBrayer, President and Chief Executive Officer. Newest notice filed Jan 18, 2013. Read the notice at the SEC.

equitySEC
Jan 2012$4 MNo. 3$2 to $10 million

Axiomed Spine Corp.: Raise no. 3, Jan 2012

Investors in this round

14 investors had bought by the notice of Feb 10, 2012: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $8 M offered; $4 M still to sell
Smallest investment taken
$8,956
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gerald G. Baty · Executive Officer
  • James M. Kuras · Executive Officer, Director
  • Patrick A McBrayer · Executive Officer, Director
  • Peter G. Kleinhenz · Executive Officer, Director
  • Ashley G. Friedman · Director
  • Keith G. Kerman · Director
  • Larry A Papasan · Director
  • Peter G. McNerney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “The proceeds of the offering are to be used for working capital purposes.”

Signed by Patrick A. McBrayer, President and Chief Executive Officer. Newest notice filed Feb 10, 2012. Read the notice at the SEC.

equitySEC
Jul 2010$10 MNo. 2$2 to $10 million

Axiomed Spine Corp.: Raise no. 2, Jul 2010

Investors in this round

13 investors had bought by the notice of Jul 28, 2010: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $15 M offered; $5 M still to sell
Smallest investment taken
$8,760
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gerald G. Baty · Executive Officer
  • James M. Kuras · Executive Officer, Director
  • Patrick A. McBrayer · Executive Officer, Director
  • Peter G. Kleinhenz · Executive Officer, Director
  • Ashley G. Friedman · Director
  • Keith G. Kerman · Director
  • Larry A. Papasan · Director
  • Peter G. McNerney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds of the offering are to be used for general corporate purposes.”

Signed by Gerald Baty, Chief Financial Officer. Newest notice filed Jul 28, 2010. Read the notice at the SEC.

equitySEC
Nov 2009$6 MNo. 1$2 to $10 million

Axiomed Spine Corp.: Raise no. 1, Nov 2009

Investors in this round

12 investors had bought by the notice of Nov 17, 2009: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $12 M offered; $5 M still to sell
Smallest investment taken
$5,262
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gerald G. Baty · Executive Officer
  • James M. Kuras · Executive Officer, Director
  • Larry A. Papasan · Executive Officer, Director
  • Patrick A. McBrayer · Executive Officer, Director
  • Peter G. Kleinhenz · Executive Officer, Director
  • Ashley G. Friedman · Director
  • Keith G. Kerman · Director
  • Peter G. McNerney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Company has reserved the right to increase this offering above the $11,500,000 amount subject to additional shareholder approval and amendment to the Company's Certificate of Incorporation.”
  • On the use of proceeds: “Proceeds of the offering are intended to be used for general corporate purposes.”

Signed by Gerald Baty, Chief Financial Officer. Newest notice filed Nov 17, 2009. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Axiomed Spine Corp. chose not to state its revenue in its newest notice of a funding round (Apr 2014).

    SEC Form D · Apr 2014

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Apr 2014

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Axiomed Spine Corp. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Axiomed Spine Corp.
NameRoleNamed in
Gerald G. BatyExecutive officerApr 2014
James M. KurasExecutive officerApr 2014
Patrick A. McBrayerExecutive officerApr 2014
Patrick A McBrayerExecutive officerFeb 2012
Peter G. KleinhenzExecutive officerFeb 2012
Larry A. PapasanExecutive officerNov 2009
Ashley G. FriedmanDirectorApr 2014
James M. KurasDirectorApr 2014
Kathleen A. TuneDirectorApr 2014
Keith G. KermanDirectorApr 2014
Larry A. PapasanDirectorApr 2014
Patrick A. McBrayerDirectorApr 2014
Peter G. KleinhenzDirectorApr 2014
Peter G. McNerneyDirectorApr 2014
Larry A PapasanDirectorFeb 2012
Patrick A McBrayerDirectorFeb 2012